Article · 29 Aug 2026
Conference abstract
Heat shock protein complex vaccines against mucosal pathogenic bacteria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
H eat shock proteins (Hsp) are highly conserved molecules with a range of functions, including acting as chaperones for cellular proteins and the ability to activate innate immune receptors. Hsp complex (HspC) vaccines, containing Hsp derived from pathogenic bacteria, are immunostimulatory without an exogenous adjuvant and induce immunity against their chaperoned bacterial proteins. HspC adjuvanticity is believed due to the ability of Hsp to activate toll-like receptors, though this has not been thoroughly examined. Further, the application of this vaccine technology against mucosal pathogens has not previously been explored. Results: Helicobacter pylori infect the stomach and are the major aetiological factor in gastric cancer. Vaccination of mice with H. pylori HspC without exogenous adjuvant produced equivalent protection, and notably increased local cytokine levels but less inflammation, as similar adjuvanted vaccines. This is the first demonstration that HspC vaccines can induce protective immunity against a mucosal pathogen without a mucosal adjuvant. Neisseria meningitides colonise the nasopharynx and in some individuals, invade the host causing meningococcal disease, including meningitis. Vaccination of mice with N. meningitides B HspC induced a strong immune response. Using MyD88-/- mice, we examined the importance of TLR signalling in the HspC mechanism of action. While the immune cytokine response was dependent on MyD88, antibody induction occurred completely independently of MyD88. Conclusion: HspC provide an effective vaccine strategy against mucosal pathogenic bacteria without the requirement for a mucosal adjuvant. While induction of a cellular response involves TLR signalling, the generation of humoral immunity occurs via a different, TLR-independent, mechanism
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Phil Sutton”
- BylineArticles whose byline prints “Jia-Xi Han”
- BylineArticles whose byline prints “Yok Teng Chionh”
- BylineArticles whose byline prints “Paola Cecchini”
- BylineArticles whose byline prints “Camilo Colaco”
